Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1994-03-10
1997-07-22
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 9321, 4351723, 435948, 514 44, 935 62, 935 70, A61K 4800, A61K 3100, C12N 1500, C12N 500
Patent
active
056501480
ABSTRACT:
Methods of genetically modifying donor cells by gene transfer for grafting into the central nervous system to treat defective, diseased or damaged cells are disclosed. The modified donor cells produce functional molecules that effect the recovery or improved function of cells in the CNS. Methods and vectors for carrying out gene transfer and grafting are described.
REFERENCES:
patent: 4497796 (1985-02-01), Salser et al.
patent: 5082670 (1992-01-01), Gage et al.
patent: 5399346 (1995-03-01), Anderson
Gage et al., Neuroscience 22 Suppl:S590, Abstract #1766p (1987).
Friedmann, T., "Implantation of Genetically Modified Cells into the Rat Brain an Approach to Restoration of CNA Functions," Gene Transfer and Gene Therapy, pp. 409-416 (1989) (Exhibit 1).
Rosenberg, K. et al., "Introduction of New Genes into Adult Rat Brain Via Grafted Cells," Soc. Ns Abstracts 13:515 (Nov. 1987) 141.15 (Exhibit 2).
Eldrup-Jorgensen, J., et al., "Antiplatelet Therapy and Vascular Grafts," Arch. Surg., 121:778-781 (1986) (Exhibit 3).
Brems, J., et al., "A Five-Year Experience with the Bovine Heterograft for Vascular Access," Arch. Surg. 121:941-944 (1986) (Exhibit 4).
Kojima, Y., et al., "Xenografts and Artificial Pancreas Transplantation," Transplantation Proceedings 19:981-983 (1987) (Exhibit 5).
Reach, G., "Bioartificial Pancreas. Present State and Future Prospects," Biomed. Biochim. Acta, 43:569-576 (1984) (Exhibit 6).
Brynitz, S., et al., "Post-Mortem Allogeneic Vein for Graft as Vascular Access in Chronic Haemodialysis," The Lancet, 900-901 (1988) (Exhibit 7).
Marion et al., Brain Research 519: 133-143 (1990).
Khillan, J.S., "Developmental and tissue-specific expression directed by the .alpha..sub.2 type 1 collagen promoter in transgenic mice," Proc. Natl. Acad. Sci. USA vol. 83, 725-729 (1986).
Rosenstein, J.M., "Neocortical Transplants in the Mammalian Brain Lack a Blood-Brain Barrier to Macromolecules," Science, 235:772-774 (1987).
Bjorklund, et al., in Neural Grafting in the Mammalian CNS, p. 709, Elsevier, Amsterdam (1985).
Sladek, et al., in Neural Transplants: Development and Function, Plenum Press, New York, (1984).
Marsden, "Movement disorders and the basal ganglia," Trends Neurosci., 9:512-515 (1986).
Vinken, et al., Eds., "Drug-induced movement disorders (tardive dyskinesia and dopa-induced dyskinesia)," Handbook of Clinical Neurology, (Tanner, author), pp. 185-204, Elsevier, Amsterdam (1986); vol. 5.
Backlund, et al., "Transplantation of adrenal medullary tissue to striatum in parkinsonism," J. Neurosurg., 62:169-173 (1985).
Madrazo, et al., "Open Microsurgical Autograft of Adrenal Medulla To The Right Caudate Nucleus in Two Patients With Intractable Parkinson's Disease," New Eng. J. Med., 316:831-834 (1987).
Bjorklund, et al., "Neural Grafting in Animal Models of Neurodegenerative Diseases," Ann. N.Y. Acad. Sci., 457:53-81 (1986).
Dunnett, et al., "Dopamine-rich transplants in experimental parkinsonism," Trends Neurosci, 6:266-270 (1983).
Gusella, et al., "A polymorphic DNA marker genetically linked to Huntington's disease," Nature, 306:234-238 (1983).
Delabar, et al., "B Amyloid Gene Duplicationin Alzheimer's Disease and Karyotypically Normal Down Syndrome," Science New York, 235:1390-1392 (1987).
Goldgaber, et al., "Characterization and Chromosomal Localization of a cDNA Encoding Brain Amyloid of Alzheimer's Disease," Science N.Y., 235:877-880 (1987).
St. George-Hyslop, et al., "The Genetic Defect Causing Familia Disease Maps on Chromosome 21," Science N.Y., 235:885-890 (1987).
Tanzi, et al., "Amyloid B Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus," Science N.Y., 235:880-884 (1987).
Baron, et al., "Genetic linkage between X-chromosome markers and bipolar affective illness," Nature, 326:289-292 (1987).
Sherrington, et al., "Localization of a susceptibility locus for schizophrenia on chromosome 5," Nature, 336:164-167 (1988).
Anderson, "Prospects for Human Gene Therapy," Science, 226:401-409 (1984).
Friedmann, et al., "Gene Therapy for Human Genetic Disease?" Science, 175:949-955 (1972).
Friedmann, Gene Therapy: Fact and Fiction in Biology's New Approaches to Disease, Cold Spring Harbor Laboratory, New York (1983).
Costantini, et al., "Correction of Murine B-Thalassemia by Gene Transfer into the Germ Line," Science, 233:1192-1194 (1986).
Mason, et al., "The Hypogonadal Mouse: Reproductive Functions Restored by Gene Therapy," Science, 234:1372-1378 (1986).
Readhead, et al., "Expression of a Myelin Basic Protein Gene in Transgenic Shiverer Mice: Correction of the Dysmyelinating Phenotype," Cell, 48:703-712 (1987).
Gilboa, et al., "Transfer and Expression of Cloned Genes Using Retroviral Vectors," BioTechniques, 4:504-512 (1986).
Shimotohno, et al., "Formation of Infectious Progeny Virus after Insertion of Herpes Simplex Thymidine Kinase Gene into DNA of an Avian Retrovirus," Cell, 26:67-77 (1981).
Wei, et al., "Construction and Isolation of a Transmissible Retrovirus Containing the src Gene of Harvey Murine Sarcoma Virus and the Thymidine Kinase Gene of Herpes Simplex Virus Type I," J. Virol., 39:935-944 (1981).
Tabin, et al., "Adaptation of a Retrovirus as a Eucaryotic Vector Transmitting the Herpes Simplex Virus Thymidine Kinase Gene," Cell Biol., 2:426-436 (1982).
Willis, et al., "Partial Phenotypic Correction of Human Lesch-Nyhan (Hypoxanthine-Guanine Phosphoribosyltransferase-deficient) Lymphoblasts with a Transmissible Retroviral Vector," J. Biol. Chem., 259:7842-7849 (1984).
Kantoff, et al., "Correction of adenosine deaminase deficiency in cultured human T and B Cells by retrovirus-mediated gene transfer," Proc. Natl. Acad. Sci. USA, 83:6563-6567 (1986).
McIvor, et al., "Human Purine Nucleoside Phosphorylase and Adenosine Deaminase: Gene Transfer into Cultured Cells and Murine Hematopoietic Stem Cells by Using Recombinant Amphotropic Retroviruses," Molec. Cell Biol., 7:838-846 (1987).
Soriano, et al., "Tissue-Specific and Ectopic Expression of Genes Introduced into Transgenic Mice by Retroviruses," Science, 234:1409-1413 (1986).
Wolff, et al., "Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes," Proc. Natl. Acad. Sci. USA, 83:3344-3348 (1987).
Khoury et al., "Enhancer Elements," Cell, 33:313-314 (1983).
Serfling, et al., "Enhancers and eukaryotic gene transcription," Trends Genet., 1:224-230 (1985).
Wolff and Friedmann, "Approaches to Gene Therapy in Disorders of Purine Metabolism," Rheumatic Dis. Clin. N. Amer., 14(2):459-477 (1988).
Eglitis and Anderson, "Retroviral Vectors for Introduction of Genes into Mammalian Cells," BioTechniques, 6:608-614 (1988).
Joyner, et al., "Retrovirus transfer of a bacterial gene into mouse haematopoietic progenitor cells," Nature, 305:556-558 (1983).
Miller, et al., "Expression of a Retrovirus Encoding Human HPRT in Mice," Science, 225:630-632 (1984).
Williams, et al., "Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse," Nature, 310:476-480 (1984).
Selden, et al., "Implantation of Genetically Engineered Fibroblasts into Mice: Implications for Gene Therapy," Science, 236:714-718 (1982).
Garver, et al., "Production of glycosylated physiologically normal human .alpha..sub.1 -antitrypsin by mouse fibroblasts modified by insertion of a human .alpha..sub.1 -antitrypsin cDNA using a retroviral vector," Proc. Nat. Acad. Sci. USA, 84:1050-1054 (1987).
St. Louis et al., "An alternative approach to somatic cell gene therapy," Proc. Nat. Acad. Sci. USA, 85:3150-3154 (1988).
Morgan, et al., "Expression of an Exogenous Growth Hormone Gene by Transplantable Human Epidermal Cells," Science, 237:1476-1479 (1987).
Geller et al., "A defective HSV-1 Vector Expresses Escherichia coli .beta.-Galactosidase in Cultured Peripheral Neurons", Science, 241:1667-1669 (1988).
Lowenstein, "Junctional Intercellular Communication and the Control of Growth," Biochem. Biophys. Acta., 560:1-65 (1979).
Gruber, et al., "Glial cells metabolically cooperate: A potential requirement for gene replacement therapy," Proc. Natl. Acad. Sci. USA, 82:6662-6666 (1985).
Heft
Friedmann Theodore
Gage Fred H.
Kawaja Michael D.
Ray Jasodhara
Rosenberg Michael B.
Chambers Jasemine C.
The Regents of the University of California
LandOfFree
Method of grafting genetically modified cells to treat defects, does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of grafting genetically modified cells to treat defects, , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of grafting genetically modified cells to treat defects, will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1558584